Compare Indofarma Tbk. (INAF) vs Panca Mitra Multiperdana Tbk. (PMMP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indofarma Tbk. vs Panca Mitra Multiperdana Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Panca Mitra Multiperdana Tbk. trades at Rp50 (market cap 129.42B). The key difference: Indofarma Tbk. is far larger — about 3× Panca Mitra Multiperdana Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | PMMP | |
|---|---|---|
Market Cap | 390.51B | 129.42B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indofarma Tbk.
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →About Panca Mitra Multiperdana Tbk.
PT Panca Mitra Multiperdana Tbk (the Company) was established in Jakarta based on Notarial Deed No. 52 of Buntario Tigris Darmawa Ng, S.H., S.E., Candidate Notary, dated August 8, 1997. The Company commenced its commercial activity in 1997. The Company’s immediate parent company is PT Tiga Makin Jaya, which is ultimately owned by Soesilo Soebardjo.
Read more on PMMP →
